GWM
AMRX icon

GK Wealth Management’s Amneal Pharmaceuticals AMRX Stock Holding History

GK Wealth Management’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$103K Buy
+5,110
New +$92.1K 0.06% 291

Other funds holding AMRX

CAM
Congress Asset Management Boston, Massachusetts $15.4B AUM 30.35% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return
SFGP
Stonebridge Financial Group (Pennsylvania) Wormleysburg, Pennsylvania $1.36B AUM 14.31% 1-Year Est. Return
VAG
VisionPoint Advisory Group Dallas, Texas $636M AUM 21.4% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
TFA
Toth Financial Advisory Leesburg, Virginia $1B AUM 19.18% 1-Year Est. Return
BONH
Bank of New Hampshire Laconia, New Hampshire $463M AUM 23.57% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return

GK Wealth Management's AMRX Position: Q3 2026 in Review

GK Wealth Management opened a new position in Amneal Pharmaceuticals (AMRX) in Q3 2026: 5,110 shares worth $103K. The stake represents 0.06% of the portfolio and ranks #291 among its holdings.

14 funds tracked by Wall St. Rank hold AMRX as of Q3 2026.

  • GK Wealth Management held 5,110 shares of Amneal Pharmaceuticals worth $103K as of Q3 2026.
  • Amneal Pharmaceuticals was a new GK Wealth Management position in Q3 2026.
  • Amneal Pharmaceuticals made up 0.06% of GK Wealth Management's portfolio in Q3 2026, its #291 holding.
  • 14 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q3 2026.

Based on GK Wealth Management's 13F filing for Q3 2026, filed 9 Oct 2026.